Time to go All-In on Celsion?
Celsion (CLSN) is a great story stock. It recently announced their Phase III trial results for liver cancer will be released by the end of January 2013. This will be a top-line release of a multinational, double-blind, placebo-controlled study of primary liver cancer. The results could make or break the company as its future pipeline is dependent on ThermoDox succeeding.
This upcoming catalyst is likely to have a huge impact on the company's valuation. The company has a current market cap of $287 million, but this will likely be drastically different by the end of the month. The CEO of Celsion has stated that this liver cancer treatment will have the potential to generate yearly revenues of $1 billion.
Mastery Bottom Line
Look for a good entry point before betting the farm on CLSN. Shares could dip down to touch the 50 day MA due to some investors not wanting to risk holding through the FDA results. A $7 - $7.50 share price would provide a great buying opportunity.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Exactly Like 7 Years Ago? 2014 Is Turning Out To Be Eerily Similar To 2007 | ZeroHedge
- Chinese Banks And 100,000 ‘Outlets’ Selling Gold!! | ZeroHedge
- 60% Of China's Water "Too Polluted To Drink" | ZeroHedge
- Energy and Staples Take the Money Cake Again | iBankCoin.com
- With Droughts and Disease Hitting Livestock Around the Globe, Animal Health Care Companies More Important Than Ever | Financial Sense
- This Raises a Few Eyebrows | iBankCoin.com
- Why Caterpillar Just Blew Away Earnings Expectations | ZeroHedge
The most relevant financial news and articles from the Internets
- We Recreated The Pepsi Challenge To See What People Really Like | Business Insider
- Congressman Jokes The NSA Is 'Probably Listening' To... | Business Insider
- Apple's Stock Split Is Gift to Retail Investors | TheStreet.com
- Here's A Quick Guide To What Traders Are Chatting About Right Now | Business Insider
- The Hidden Costs Of College Add Up To An Extra $10,000 A Year | Business Insider
- Shopping Cart... | Business Insider
- LIVE! Real Madrid Scores A Beautiful Counterattacking Goal Against... | Business Insider